Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H23N3.ClH |
| Molecular Weight | 329.867 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CN(C)CCN(C)N1C=C(C2=C1C=CC=C2)C3=CC=CC=C3
InChI
InChIKey=LWSDQRSJVPCQRC-UHFFFAOYSA-N
InChI=1S/C19H23N3.ClH/c1-20(2)13-14-21(3)22-15-18(16-9-5-4-6-10-16)17-11-7-8-12-19(17)22;/h4-12,15H,13-14H2,1-3H3;1H
| Molecular Formula | C19H23N3 |
| Molecular Weight | 293.406 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Binedaline is a drug that was investigated as an antidepressant in the 1980s. It`s development for the treatment of major depressive disorder was discontinued. It acts as a selective norepinephrine reuptake inhibitor (Ki = 25 nM), with relatively insignificant influence on the serotonin (Ki = 847 nM) and dopamine (Ki >= 2 µM) transporters.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Pharmacological profile of binedaline, a new antidepressant drug. | 1989-04 |
|
| Binedaline binding to plasma proteins and red blood cells in humans. | 1985-07 |
|
| A controlled double-blind study comparing binedaline and imipramine in the treatment of endogenous depression. | 1984 |
Sample Use Guides
The effects of two single oral doses of binedaline (50 and 100 mg), imipramine (75 mg) and placebo were compared on a range of psychological tasks (logical reasoning, the Stroop test, and five-choice serial reaction) in healthy young volunteers.
Route of Administration:
Oral
Binedaline and desmethylbinedaline were potent inhibitors of the uptake of norepinephrine in synaptosomes from rat cerebral cortex (Ki = 25 and 29 nM, respectively). Binedaline also inhibited 5-HT uptake with a weak affinity (Ki = 847 nM) but was inactive as an inhibitor of dopamine uptake in synaptosomes from rat striatum (Ki greater than 2 uM).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:16:58 GMT 2025
by
admin
on
Mon Mar 31 19:16:58 GMT 2025
|
| Record UNII |
WEK9FVT37G
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m84
Created by
admin on Mon Mar 31 19:16:58 GMT 2025 , Edited by admin on Mon Mar 31 19:16:58 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB25841
Created by
admin on Mon Mar 31 19:16:58 GMT 2025 , Edited by admin on Mon Mar 31 19:16:58 GMT 2025
|
PRIMARY | |||
|
100000089669
Created by
admin on Mon Mar 31 19:16:58 GMT 2025 , Edited by admin on Mon Mar 31 19:16:58 GMT 2025
|
PRIMARY | |||
|
57647-35-5
Created by
admin on Mon Mar 31 19:16:58 GMT 2025 , Edited by admin on Mon Mar 31 19:16:58 GMT 2025
|
PRIMARY | |||
|
260-877-2
Created by
admin on Mon Mar 31 19:16:58 GMT 2025 , Edited by admin on Mon Mar 31 19:16:58 GMT 2025
|
PRIMARY | |||
|
DTXSID50973230
Created by
admin on Mon Mar 31 19:16:58 GMT 2025 , Edited by admin on Mon Mar 31 19:16:58 GMT 2025
|
PRIMARY | |||
|
42509
Created by
admin on Mon Mar 31 19:16:58 GMT 2025 , Edited by admin on Mon Mar 31 19:16:58 GMT 2025
|
PRIMARY | |||
|
WEK9FVT37G
Created by
admin on Mon Mar 31 19:16:58 GMT 2025 , Edited by admin on Mon Mar 31 19:16:58 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |